Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias
暂无分享,去创建一个
[1] Sabine Van Huffel,et al. An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES , 2007, NMR in biomedicine.
[2] W. Lowe,et al. Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells. , 1996, The American journal of physiology.
[3] C. Gandolfo,et al. Kinetics of creatine in blood and brain after intraperitoneal injection in the rat , 2003, Brain Research.
[4] Ranjan Duara,et al. Conversion to Dementia among Two Groups with Cognitive Impairment , 2004, Dementia and Geriatric Cognitive Disorders.
[5] B. Meier,et al. Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .
[6] Klaas Nicolay,et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.
[7] H. Betz,et al. The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues. , 1994, Biochemical and biophysical research communications.
[8] K. Kiuchi,et al. Fractional Anisotropy–Threshold Dependence in Tract-Based Diffusion Tensor Analysis: Evaluation of the Uncinate Fasciculus in Alzheimer Disease , 2009, American Journal of Neuroradiology.
[9] Stephen K Fisher,et al. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.
[10] F. Palmer,et al. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. , 1989, Biochimica et biophysica acta.
[11] D. A. Godfrey,et al. Distribution of myo‐Inositol in the Cat Cochlear Nucleus , 1982, Journal of neurochemistry.
[12] D van Ormondt,et al. Cramér–Rao bounds: an evaluation tool for quantitation , 2001, NMR in biomedicine.
[13] N. Fayed,et al. Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study , 2011, BMJ Open.
[14] J. Shapiro,et al. Effects of hypernatremia on organic brain osmoles. , 1990, The Journal of clinical investigation.
[15] J. McCracken,et al. Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder , 2001, Neuropsychopharmacology.
[16] Khadija Iqbal,et al. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] Olaf Sporns,et al. The Human Connectome: A Structural Description of the Human Brain , 2005, PLoS Comput. Biol..
[18] S. Van Huffel,et al. Lineshape estimation for magnetic resonance spectroscopy (MRS) signals: self-deconvolution revisited , 2009 .
[19] Anthony J. Spychalla,et al. Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy , 2014, The Journal of Neuroscience.
[20] L. Martí-Bonmatí,et al. Cognitive impairment: classification by 1H magnetic resonance spectroscopy , 2004, European journal of neurology.
[21] R. Edelman,et al. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. , 2004, AJNR. American journal of neuroradiology.
[22] W. Markesbery,et al. Neuropathologic alterations in mild cognitive impairment: a review. , 2010, Journal of Alzheimer's disease : JAD.
[23] J. Neale,et al. Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes , 2006, Journal of neurochemistry.
[24] J. Moll,et al. Contribution of 1H Spectroscopy to a Brief Cognitive-Functional Test Battery for the Diagnosis of Mild Alzheimer’s Disease , 2012, Dementia and Geriatric Cognitive Disorders.
[25] William S. Ball,et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.
[26] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[27] B. Reisberg,et al. Mild cognitive impairment in the elderly , 1991, Neurology.
[28] M. Goldberg,et al. Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.
[29] Zenon Starčuk,et al. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package , 2009 .
[30] T. Taoka,et al. Global and region-specific analyses of apparent diffusion coefficient in dentatorubral-pallidoluysian atrophy. , 2006, AJNR. American journal of neuroradiology.
[31] A. Yamauchi,et al. Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. , 1992, The Journal of biological chemistry.
[32] J. Parrish,et al. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. , 1999, The American journal of psychiatry.
[33] N. Fayed,et al. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. , 2008, Academic radiology.
[34] D M Doddrell,et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.
[35] R. Gruetter,et al. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin‐induced diabetic rats , 2009, Journal of neurochemistry.
[36] M. Norenberg,et al. Osmotic regulation ofmyo-inositol uptake in primary astrocyte cultures , 1994, Neurochemical Research.
[37] Liang Peng,et al. Energy Metabolism in Astrocytes: High Rate of Oxidative Metabolism and Spatiotemporal Dependence on Glycolysis/Glycogenolysis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] James S Babb,et al. Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. , 2013, Magnetic resonance imaging.
[39] R. Kreis. Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.
[40] R. Belmaker,et al. Valproate decreases inositol biosynthesis , 2004, Biological Psychiatry.
[41] A. Urazaev,et al. N-Acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber , 2001, Neuroscience.
[42] V. Govindaraju,et al. Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.
[43] Michael Weiner,et al. Breakdown of Brain Connectivity Between Normal Aging and Alzheimer's Disease: A Structural k-Core Network Analysis , 2013, Brain Connect..
[44] C. Jack,et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. , 2008, Radiology.
[45] N. Schuff,et al. Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging , 2006, Alzheimer disease and associated disorders.
[46] Liang Peng,et al. Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH , 2012, Neurochemistry International.
[47] R. Blakely,et al. Expression of the rat brain creatine transporter in situ and in transfected HeLa cells. , 1996, Developmental neuroscience.
[48] F. Jessen,et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients , 2001, Neurology.
[49] J. Konvalinka,et al. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer , 2006, The EMBO journal.
[50] E. Tangalos,et al. Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.
[51] Alexander Leemans,et al. Disruption of cerebral networks and cognitive impairment in Alzheimer disease , 2013, Neurology.
[52] P. Comfurius,et al. Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.
[53] R S Menon,et al. Spectroscopic lineshape correction by QUECC: Combined QUALITY deconvolution and eddy current correction , 2000, Magnetic resonance in medicine.
[54] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[55] Sabine Van Huffel,et al. Java-based framework for processing and displaying short-echo-time magnetic resonance spectroscopy signals , 2007, Comput. Methods Programs Biomed..
[56] Guy B. Williams,et al. Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. , 2011, Brain : a journal of neurology.
[57] Heinrich Lanfermann,et al. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy , 2009, Psychiatry Research: Neuroimaging.
[58] M. Albert,et al. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. , 2012, The Journal of neuropsychiatry and clinical neurosciences.
[59] Mojtaba Zarei,et al. White matter tract integrity in aging and Alzheimer's disease , 2009, Human brain mapping.
[60] R. Morris,et al. The relationship between white matter brain metabolites and cognition in normal aging: The GENIE study , 2007, Brain Research.
[61] K. Kantarci. Magnetic resonance spectroscopy in common dementias. , 2013, Neuroimaging clinics of North America.
[62] D. Dubowitz,et al. Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain , 1998, Magnetic Resonance in Medicine.
[63] D. Le Bihan,et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. , 1999, Stroke.
[64] R. Koehler,et al. Astrocyte glutamine synthetase: Importance in hyperammonemic syndromes and potential target for therapy , 2010, Neurotherapeutics.
[65] R. Kauppinen,et al. Nondestructive Detection of Glutamate by 1H Nuclear Magnetic Resonance Spectroscopy in Cortical Brain Slices from the Guinea Pig: Evidence for Changes in Detectability During Severe Anoxic Insults , 1991, Journal of neurochemistry.
[66] J. Lapointe,et al. Effects of hyperosmolarity on the Na+ -myo-inositol cotransporter SMIT2 stably transfected in the Madin-Darby canine kidney cell line. , 2008, American journal of physiology. Cell physiology.
[67] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[68] C. Barnes,et al. Age-related changes in parahippocampal white matter integrity: A diffusion tensor imaging study , 2012, Neuropsychologia.
[69] Masaaki Hori,et al. Visualizing non-Gaussian diffusion: clinical application of q-space imaging and diffusional kurtosis imaging of the brain and spine. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[70] P. Kaldis,et al. 'Hot spots' of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus. , 1996, Developmental neuroscience.
[71] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[72] C Bachmann,et al. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. , 2001, Brain research. Molecular brain research.
[73] Daniel Rueckert,et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.
[74] J. Chatton,et al. Identification of a mammalian H+‐myo‐inositol symporter expressed predominantly in the brain , 2001, The EMBO journal.
[75] Linda Chang,et al. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. , 2008, Magnetic resonance imaging.
[76] Timothy Edward John Behrens,et al. Automated Probabilistic Reconstruction of White-Matter Pathways in Health and Disease Using an Atlas of the Underlying Anatomy , 2011, Front. Neuroinform..
[77] Rolf Gruetter,et al. Handling macromolecule signals in the quantification of the neurochemical profile. , 2012, Journal of Alzheimer's disease : JAD.
[78] Lawrence R. Frank,et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.
[79] Masahiko Watanabe,et al. The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] H. Henry,et al. Expression and function of AGAT, GAMT and CT1 in the mammalian brain. , 2007, Sub-cellular biochemistry.
[81] A. Schousboe,et al. 1 Glutamine, Glutamate, and GABA: Metabolic Aspects , 2007 .
[82] H. Happe,et al. In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system , 1995, The Journal of comparative neurology.
[83] S. Van Huffel,et al. Different quantification algorithms may lead to different results: a comparison using proton MRS lipid signals , 2014, NMR in biomedicine.
[84] P. Steiner,et al. Regulated exocytosis of an H+/myo‐inositol symporter at synapses and growth cones , 2004, The EMBO journal.
[85] M. Portero-Otín,et al. Non-Enzymatic Modification of Aminophospholipids by Carbonyl-Amine Reactions , 2013, International journal of molecular sciences.
[86] T. Taoka,et al. Diffusion anisotropy and diffusivity of white matter tracts within the temporal stem in Alzheimer disease: evaluation of the "tract of interest" by diffusion tensor tractography. , 2006, AJNR. American journal of neuroradiology.
[87] J. Molinuevo,et al. Longitudinal Study of Amnesic Patients at High Risk for Alzheimer’s Disease: Clinical, Neuropsychological and Magnetic Resonance Spectroscopy Features , 2007, Dementia and Geriatric Cognitive Disorders.
[88] C. Jack,et al. MRI and MRS predictors of mild cognitive impairment in a population-based sample , 2013, Neurology.
[89] Barbara Palumbo,et al. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging , 1997, Mechanisms of Ageing and Development.
[90] Huaxi Xu,et al. APP processing in Alzheimer's disease , 2011, Molecular Brain.
[91] P. V. van Zijl,et al. Comparison of single‐shot localization methods (steam and press) for In vivo proton NMR spectroscopy , 1989, NMR in biomedicine.
[92] Andrew Simmons,et al. Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. , 2010, Journal of Alzheimer's disease : JAD.
[93] Peter Mattsson,et al. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1h magnetic resonance spectroscopy (MRS) study , 2010, Acta radiologica.
[94] B. Miller,et al. White matter damage in primary progressive aphasias: a diffusion tensor tractography study. , 2011, Brain : a journal of neurology.
[95] Anders H. Andersen,et al. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease , 2010, NeuroImage.
[96] A. Mitchell,et al. Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.
[97] K. Bushara,et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status , 2010, Movement disorders : official journal of the Movement Disorder Society.
[98] Massimo Filippi,et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. , 2011, Radiology.
[99] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[100] R. Augustin. The protein family of glucose transport facilitators: It's not only about glucose after all , 2010, IUBMB life.
[101] S. Nakanishi,et al. Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb , 1993, Nature.
[102] N. Herrmann,et al. Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.
[103] N. Fayed,et al. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. , 2005, The American journal of psychiatry.
[104] C Boesch,et al. Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.
[105] S. Van Huffel,et al. MRS signal quantitation: a review of time- and frequency-domain methods. , 2008, Journal of magnetic resonance.
[106] D. Head,et al. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.
[107] S. Love,et al. Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.
[108] Wolfgang Grodd,et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.
[109] S. Blüml,et al. Developmental changes in choline‐ and ethanolamine‐containing compounds measured with proton‐decoupled 31P MRS in in vivo human brain , 1999, Magnetic resonance in medicine.
[110] Shi-Jiang Li,et al. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.
[111] R. Gonzalez,et al. Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. , 2005, AJNR. American journal of neuroradiology.
[112] Stefan Klöppel,et al. Automated tractography of the cingulate bundle in Alzheimer's disease: A multicenter DTI study , 2012, Journal of magnetic resonance imaging : JMRI.
[113] S. Wisniewski,et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.
[114] Bruce Fischl,et al. Regional white matter volume differences in nondemented aging and Alzheimer's disease , 2009, NeuroImage.
[115] G. Fein,et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. , 1996, Radiology.
[116] M. Targosz-Gajniak,et al. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia , 2013, Journal of the Neurological Sciences.
[117] R. Pintelon,et al. A new FIR filter technique for solvent suppression in MRS signals. , 2009, Journal of magnetic resonance.
[118] D. Budd,et al. Presynaptic receptors and the control of glutamate exocytosis , 1996, Trends in Neurosciences.
[119] A. Simmons,et al. Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. , 2005, Archives of general psychiatry.
[120] T. Ishihara,et al. An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer’s disease , 2004, Acta Neuropathologica.
[121] Dost Öngür,et al. Quantification of J‐resolved proton spectra in two‐dimensions with LCModel using GAMMA‐simulated basis sets at 4 Tesla , 2009, NMR in biomedicine.
[122] 渡辺 俊之. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging , 2011 .
[123] M. Bozzali,et al. Assessing Corpus Callosum Changes in Alzheimer's Disease: Comparison between Tract-Based Spatial Statistics and Atlas-Based Tractography , 2012, PloS one.
[124] F. Lang,et al. Up‐regulation of hypertonicity‐activated myo‐inositol transporter SMIT1 by the cell volume‐sensitive protein kinase SGK1 , 2008, The Journal of physiology.
[125] A. Harwood,et al. Lithium therapy and signal transduction. , 2000, Trends in pharmacological sciences.
[126] J. Frahm,et al. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.
[127] J. Neale,et al. N‐Acetylaspartylglutamate Inhibits Forskolin‐Stimulated Cyclic AMP Levels via a Metabotropic Glutamate Receptor in Cultured Cerebellar Granule Cells , 1993, Journal of neurochemistry.
[128] K. Strange,et al. In situ localization and osmotic regulation of the Na(+)-myo-inositol cotransporter in rat brain. , 1996, American Journal of Physiology.
[129] R. Shulman,et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[130] Masahiko Watanabe,et al. Evidence for creatine biosynthesis in Müller glia , 2005, Glia.
[131] Masahiko Watanabe,et al. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK‐Mi and CK‐B suggest a novel neuron–glial relationship for brain energy homeostasis , 2004, The European journal of neuroscience.
[132] C. Jack,et al. Risk of dementia in MCI , 2009, Neurology.
[133] Clifford R. Jack,et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.
[134] B. Fischl,et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease , 2010, Neurobiology of Aging.
[135] B D Ross,et al. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. , 1995, The Journal of clinical investigation.
[136] R. Gruetter,et al. evelopmental and metabolic brain alterations in rats exposed to bisphenol during gestation and lactation , 2010 .
[137] N. Schuff,et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.
[138] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[139] B. Peterson,et al. Spectral resolution amelioration by deconvolution (SPREAD) in MR spectroscopic imaging , 2009, Journal of magnetic resonance imaging : JMRI.
[140] H. Gertz,et al. The prognosis of mild cognitive impairment in the elderly. , 1998, Journal of neural transmission. Supplementum.
[141] G. Alexander,et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.
[142] M. Aksenova,et al. The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients , 1991, FEBS letters.
[143] Erika Zambello,et al. Evaluation of expression and function of the H+/myo-inositol transporter HMIT , 2009, BMC Cell Biology.
[144] S. Van Huffel,et al. Quantification of magnetic resonance spectroscopy signals with lineshape estimation , 2011 .
[145] Stefan Neubauer,et al. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. , 2004, Human molecular genetics.
[146] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[147] R. Reilmann,et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease , 2010, Neurology.
[148] W. Sherman,et al. Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. , 1977, Analytical biochemistry.
[149] D. Schoepp,et al. Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.
[150] B. L. Miller,et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients , 2005, Neurology.
[151] S. M. de la Monte,et al. Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.
[152] Role of Cytosolic Calcium-Dependent Phospholipase A2 in Alzheimer's Disease Pathogenesis , 2012, Molecular Neurobiology.
[153] H. Henry,et al. AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: A review , 2008, Journal of Inherited Metabolic Disease.
[154] Linda Chang,et al. Effects of age and sex on brain glutamate and other metabolites. , 2009, Magnetic resonance imaging.
[155] Patrizia Mecocci,et al. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy , 2006, Neurobiology of Aging.
[156] M. Sdika,et al. Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.
[157] S. Rose,et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[158] P. Doraiswamy,et al. Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? , 1998, The Journal of clinical psychiatry.
[159] N Roberts,et al. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. , 2001, Cerebral cortex.
[160] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[161] Declan G. M. Murphy,et al. Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease , 2011, NeuroImage.
[162] K. Strange,et al. Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells. , 1992, The American journal of physiology.
[163] Sander Martens,et al. Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis , 2013, Neuroscience & Biobehavioral Reviews.
[164] J. Fisk,et al. Five-Year Outcomes for Dementia Defined Solely by Neuropsychological Test Performance , 2003, Neuroepidemiology.